| Literature DB >> 28091938 |
Kanika Aggarwal1, Aniruddha Agarwal1,2, Ankit Deokar1, Sarakshi Mahajan1, Ramandeep Singh1, Reema Bansal1, Aman Sharma3, Mangat R Dogra1, Vishali Gupta4.
Abstract
BACKGROUND: The aim of this study is to determine the differences in optical coherence tomography angiography (OCTA) features of acute Vogt-Koyanagi-Harada disease (VKH) and acute central serous chorioretinopathy (CSC). Clinical and imaging data of patients with acute CSC and VKH in a tertiary-care institute were analyzed. Multimodal imaging including fluorescein angiography, indocyanine green angiography (ICGA), and enhanced-depth imaging OCT were performed. OCTA images were analyzed for alterations in retinochoroidal microvasculature.Entities:
Keywords: Central serous chorioretinopathy; EDI-OCT; Indocyanine green angiography; Multimodal imaging; Optical coherence tomography angiography; Vogt-Koyanagi-Harada syndrome
Year: 2017 PMID: 28091938 PMCID: PMC5236035 DOI: 10.1186/s12348-016-0122-z
Source DB: PubMed Journal: J Ophthalmic Inflamm Infect ISSN: 1869-5760
Demographic data and clinical features of patients with acute central serous chorioretinopathy included in the study
| Patient no. | Sex | Age (years) | Eye | BCVA | Anterior segment features | Posterior segment features | Systemic features and steroid exposure | Total follow-up (weeks) |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 32 | OD | 0.8 | – | SSRD and PED | Nil | 6 |
| OS | 0.2 | – | ||||||
| 2 | M | 41 | OD | 0 | – | – | Nil | 12 |
| OS | 0.2 | SSRD | ||||||
| 3 | M | 33 | OD | 0.2 | – | – | Local steroid use for dermatological condition | 8 |
| OS | 0.8 | SSRD | ||||||
| 4 | F | 38 | OD | 0 | – | – | Oral herbal medications for hypertension | 2 |
| OS | 0.2 | SSRD and PED | ||||||
| 5 | M | 37 | OD | 0.8 | – | SSRD | Oral herbal medications for renal calculi | 8 |
| OS | 0 | – | ||||||
| 6 | M | 32 | OD | 0.2 | – | – | Local steroid use for tinea | 4 |
| OS | 0.48 | SSRD | ||||||
| 7 | M | 35 | OD | 0 | – | SSRD and PED | Oral steroids for asthma | 6 |
| OS | 0 | – | ||||||
| 8 | M | 32 | OD | 0 | – | PED | Nil | 12 |
| OS | 0.48 | SSRD and PED | ||||||
| 9 | M | 27 | OD | 0 | – | – | Nil | 14 |
| OS | 0.3 | SSRD and PED | ||||||
| 10 | M | 32 | OD | 0.2 | – | SSRD | Nil | 9 |
| OS | 0 | – | ||||||
| 11 | F | 24 | OD | 0.1 | – | SSRD and PED | Local steroid use for dermatological condition | 5 |
| OS | 0.1 | – | ||||||
| 12 | M | 44 | OD | 0.3 | – | SSRD | Oral steroids for joint pains | 10 |
| OS | 0 | – | ||||||
| 13 | M | 38 | OD | 0 | – | – | Nil | 12 |
| OS | 0.1 | SSRD and PED | ||||||
| 14 | M | 39 | OD | 0.2 | – | SSRD and PED | Oral herbal medications for fatigue | 4 |
| OS | 0 | – |
BCVA best-corrected visual acuity, F female, M male, OD right eye, OS left eye, PED pigment epithelial detachment, SSRD subfoveal serous retinal detachment
Demographic data and clinical features of patients with acute Vogt-Koyanagi-Harada disease included in the study
| Patient no. | Sex | Age (years) | Eye | BCVA | Anterior segment features | Posterior segment features | Systemic features | Total follow-up (weeks) |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 36 | OD | 0 | No cells/flare/KPs | – | – | 5 |
| OS | 1 | No cells/flare/KPs | Disc edema; SSRD | |||||
| 2 | F | 39 | OD | 0.8 | No cells/flare/KPs | Disc edema | Headache | 3 |
| OS | 0.8 | No cells/flare/KPs | SSRD; multiple choroiditis lesions | |||||
| 3 | F | 27 | OD | 0 | No cells/flare/KPs | Chorioretinal scars | Headache and fever | 13 |
| OS | 0.6 | Cells 0.5+, pigment over anterior lens surface | Multiple choroiditis lesions; SSRD | |||||
| 4 | M | 33 | OD | 0.8 | Cells 1+, pigment over anterior lens surface | Vitritis, disc edema; SSRD | – | 14 |
| OS | 0.8 | No cells/flare/KPs | Disc edema; SSRD | |||||
| 5 | F | 19 | OD | 0 | No cells/flare/KPs | – | Headache | 14 |
| OS | 1 | No cells/flare/KPs | Multiple choroiditis lesions | |||||
| 6 | F | 60 | OD | HMCF | Cells 3+, flare + | Vitritis; increased choroidal thickness | Headache; sensorineural hearing loss + | 1 |
| OS | 1 | Cells 2+, flare + | Vitritis; increased choroidal thickness | |||||
| 7 | M | 19 | OD | 0 | No cells/flare/KPs | Multiple choroiditis lesions and SSRD | – | 41 |
| OS | 0.9 | No cells/flare/KPs | Multiple choroiditis lesions and SSRD | |||||
| 8 | F | 32 | OD | 1 | No cells/flare/KPs | Disc edema | Headache | 5 |
| OS | 0.1 | No cells/flare/KPs | Multiple choroiditis lesions | |||||
| 9 | F | 5 | OD | 0.8 | No cells/flare/KPs | SSRD; increased choroidal thickness | – | 12 |
| OS | 0.8 | No cells/flare/KPs | SSRD; vitritis; increased choroidal thickness | |||||
| 10 | F | 28 | OD | 0.2 | No cells/flare/KPs | SSRD; increased choroidal thickness | Headache | 10 |
| OS | 0.48 | No cells/flare/KPs | SSRD; increased choroidal thickness |
BCVA best-corrected visual acuity, F female, M male, OD right eye, OS left eye
Multimodal imaging features of alterations observed on optical coherence tomography angiography in patients with acute Vogt-Koyanagi-Harada syndrome and acute central serous chorioretinopathy
| Feature | Condition | Appearance of choriocapillaris on OCTA | Associated retinal/pigment epithelial/choroidal features | Features on EDI-OCT and/or ICGA |
|---|---|---|---|---|
| Dense dark areas | CSC | Single well-defined uniformly hyporeflective areas of apparent flow void | PED | Hyper-reflective dome-shaped elevation of the RPE on EDI-OCT |
| Mottled dark areas | CSC | Irregular, areas of mixed hypo- and hyper-reflectance with ill-defined margins | SSRD | Homogenous hyporeflective space between the neurosensory retina and RPE on EDI-OCT |
| Multifocal dark spots | VKH | Multiple, round-to-oval, well-defined, variably sized hyporeflective areas suggestive of choriocapillaris flow void | Choroidal inflammatory foci | Choriocapillaris ischemia on ICGA |
Fig. 1Multimodal imaging of a patient with acute central serous chorioretinopathy (CSC) (subject #6). Fundus photograph (a) of the left eye shows presence of subretinal fluid (SRF) in the macula. Fluorescein angiography (FA) in the early phase (b) shows pin-point hyperfluorescence superonasal and inferotemporal to the fovea. The late phase FA (c) shows expanding dot sign with pooling of the dye. The en face optical coherence tomography angiography (OCTA) (d) shows the presence of mottled dark areas which corresponded to the dark areas representing signal loss on the corresponding structural en face OCT at the level of the choriocapillaris (e) and the outer retina (f). Horizontal (g) and vertical (h) cross-sectional OCT B-scan shows the presence of SRF in the macula
Fig. 2Multimodal imaging of a patient with acute central serous chorioretinopathy (CSC) (subject #8). Fundus photograph of the right eye (a) shows presence of multiple pigment epithelial detachments (PEDs) in the macula. (b) On fluorescein angiography (FA), there is hyperfluorescence corresponding to the PEDs. (c) The en face optical coherence tomography angiography (OCTA) shows presence of dense dark areas at the level of the choriocapillaris. (d) The structural en face OCT shows hyporeflectance suggestive of loss of signal transmission in the areas of PEDs. The horizontal (e) and vertical (f) cross-sectional OCT B-scans show dome-shaped PEDs
Fig. 3Fundus photography, combined fluorescein angiography (FA) and indocyanine green angiography (ICGA), and optical coherence tomography angiography (OCTA) of a patient with acute Vogt-Koyanagi-Harada (VKH) disease (subject #3). Fundus photograph (a) shows presence of vitritis with multiple yellowish choroiditis lesions in the posterior pole. Combined FA and ICGA in the early frame (b) shows early pin-point hyperfluorescence on FA and multiple hypocyanescent lesions on ICGA. In the late frame (d), there is progressive hyperfluorescence with pooling of the dye on FA and persistence of hypocyanescent lesions on ICGA suggestive of choriocapillaris ischemia. The en face OCTA (c) at the level of choriocapillaris shows presence of multifocal dark spots which are variably sized and corresponded to the hypocyanescent lesions on ICGA. Few such dark foci have been demarcated with yellow dashed line. The structural en face OCT scan shows only mild signal loss in the area of subretinal fluid but no loss in the areas of dark spots (e). The corresponding cross-sectional OCT B-scan (f) shows presence of subretinal fluid
Fig. 4Comparison between the superficial and deep retinal plexus (SCP and DCP) and outer retinal slab of optical coherence tomography angiography (OCTA) of patients with central serous chorioretinopathy (CSC) (a–c) and Vogt-Koyanagi-Harada (VKH) disease (d–f). The OCTA image and the corresponding structural en face image at the SCP and DCP of patients with CSC and VKH (a, b, d, and e) do not show any abnormalities. The avascular outer retinal slab in CSC and VKH (c, f) shows few dark areas (yellow arrows) due to the signal loss from subretinal fluid as visualized in the corresponding structural en face OCT